Search Results - Hans Tesch

Refine Results
  1. 1
    The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway

    The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway by Martina Vockerodt, Birgit Haier, Peter Buttgereit, Hans Tesch, Dieter Kube

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin

    Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin by Christian Maihöfner, Ingo Diel, Hans Tesch, Tamara Quandel, Ralf Baron

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the prospective German TMK cohort study

    Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the prospective German TMK cohort study by Thomas Fietz, Hans Tesch, Jacqueline Rauh, Emil Boller, Lisa Kruggel, Martina Jänicke, Norbert Marschner

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony‐stimulating factor and erythropoietin

    Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony‐stimulating factor and erythropoietin by Luisa Mantovani, Giuseppe Lentini, Bettina Hentschel, P. Dias Wickramanayake, Markus Loeffler, Volker Diehl, Hans Tesch

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

    Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia by T. Steinmetz, B. Tschechne, Olof Harlin, B. Klement, Melanie Franzem, J. Wamhoff, Hans Tesch, Robert Rohrberg, Norbert Marschner

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)

    Favorable outcome of patients with relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional... by Andreas Josting, I. Katay, U. Rueffer, Stefan Winter, Hans Tesch, Andreas Engert, Volker Diehl, P. Dias Wickramanayake

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study

    Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study by Jan Schröder, Thomas Fietz, Andreas Köhler, Volker Petersen, Hans Tesch, Lisa Spring, A. Fleitz, Martina Jänicke, Norbert Marschner

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

    Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study by Hans-Christian Kolberg, Marco Colleoni, Georgia Demetriou, Patrícia Xavier Santi, Hans Tesch, Yasuhiro Fujiwara, Zorica Tomašević, Vladimir Hanes

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    STAT3 is constitutively activated in Hodgkin cell lines

    STAT3 is constitutively activated in Hodgkin cell lines by Dieter Kube, Udo Holtick, Martina Vockerodt, Tahamtan Ahmadi, Birgit Haier, Iris Behrmann, Peter C. Heinrich, Volker Diehl, Hans Tesch

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Clinical experience with Zarzio® in Europe: what have we learned?

    Clinical experience with Zarzio® in Europe: what have we learned? by Pere Gascón, Hans Tesch, Karl Verpoort, Maria Sofia Rosati, Nello Salesi, Samir Agrawal, Nils Wilking, Helen F. Barker, Michael Muenzberg, Matthew Turner

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease by Volker Diehl, M. Sieber, U. Rüffer, B. Lathan, Dirk Hasenclever, Michael Pfreundschuh, Markus Loeffler, D. Lieberz, P. Koch, Michael Adler, Hans Tesch

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease

    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgk... by Volker Diehl, Markus Loeffler, Michael Pfreundschuh, U. Ruehl, Dirk Hasenclever, Hiltrud Nisters-Backes, M. Sieber, Kirby L. Smith, Hans Tesch, Wilhelm Geilen

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

    Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease by Martin R. Weihrauch, Daniel Ré, Klemens Scheidhauer, Sascha Ansén, Markus Dietlein, Stefanie Bischoff, Heribert Bohlen, Jürgen Wolf, H Schicha, Volker Diehl, Hans Tesch

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Systemic therapy in metastatic renal cell carcinoma

    Systemic therapy in metastatic renal cell carcinoma by Jens Bedke, Thomas Gauler, Viktor Grünwald, Axel Hegele, Edwin Herrmann, Stefan Hinz, Jan Janssen, Stephan Schmitz, Martin Schostak, Hans Tesch, Stefan Zastrow, Kurt Miller

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease by Volker Diehl, Jeremy Franklin, Michael Pfreundschuh, B. Lathan, Ursula Paulus, Dirk Hasenclever, Hans Tesch, Richard Herrmann, Bernd Dörken, Hans–Konrad Müller–Hermelink, E. Dühmke, Markus Loeffler

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

    Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations by Matti Aapro, Ralph V. Boccia, Robert Leonard, Carlos Camps, Mario Campone, Sylvain Choquet, Marco Danova, John A. Glaspy, Iwona Hus, Hartmut Link, Thamer Sliwa, Hans Tesch, Vicente Valero

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment

    Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment by U. Rueffer, Kai Breuer, Andreas Josting, B. Lathan, M. Sieber, Oliver Manzke, F. Grotenhermen, Hans Tesch, Henning Bredenfeld, P. Koch, Hiltrud Nisters-Backes, Jennifer Moriatis Wolf, Andreas Engert, Volker Diehl

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study

    Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study by Jens Huober, Gunter von Minckwitz, Carsten Denkert, Hans Tesch, Erich Weiß, Dirk M. Zahm, Antje Belau, F Khandan, Maik Hauschild, Christoph Thomssen, B. Högel, Silvia Darb‐Esfahani, Keyur Mehta, Sibylle Loibl

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma

    A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma by Andreas Engert, Volker Diehl, Roland Schnell, A. Radszuhn, Maria-Theresia Hatwig, Silke Drillich, Gisela Schön, Heribert Bohlen, Hans Tesch, Martin‐Leo Hansmann, Stefan Barth, John Schindler, Victor Gheţie, Jonathan W. Uhr, Ellen S. Vitetta

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

    Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial by Sabine Riethdorf, Volkmar Müller, Sibylle Loibl, Valentina Nekljudova, Karsten Weber, Jens Huober, Tanja Fehm, Iris Schrader, J. Hilfrich, Frank Holms, Hans Tesch, Christian Schem, Gϋnter von Minckwitz, Michael Untch, Klaus Pantel

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: